articleTrends in ImmunologyApr 2, 2020HYBRID OA

Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses

SJShibo JiangCDChristopher D. HillyerLDLanying Du

New York Blood Center · Fudan University

PubMed
Indexed incrossrefpubmed

Abstract

Coronavirus (CoV) disease 2019 (COVID-19) caused by severe acute respiratory syndrome (SARS)-CoV-2 (also known as 2019-nCoV) is threatening global public health, social stability, and economic development. To meet this challenge, this article discusses advances in the research and development of neutralizing antibodies (nAbs) for the prevention and treatment of infection by SARS-CoV-2 and other human CoVs. Coronavirus (CoV) disease 2019 (COVID-19) caused by severe acute respiratory syndrome (SARS)-CoV-2 (also known as 2019-nCoV) is threatening global public health, social stability, and economic development. To meet this challenge, this article discusses advances in the research and development of neutralizing…

Citation impact

935
total citations
FWCI
22.62
Percentile
100%
References
15
Citations per year

Authors

3

Topics & keywords

Topics
Keywords
  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
  • Coronavirus disease 2019 (COVID-19)
  • Virology
  • 2019-20 coronavirus outbreak
  • Antibody
  • Coronavirus
  • Betacoronavirus
  • Sars virus
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding